Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Anesth Analg ; 2024 Feb 05.
Artigo em Inglês | MEDLINE | ID: mdl-38315621

RESUMO

BACKGROUND: Remimazolam is a recently marketed ultrashort-acting benzodiazepine. This drug is considered safe and effective during general anesthesia; however, limited information is available about its effects on patients undergoing cardiac surgery. Therefore, the present study was conducted to evaluate the efficacy and hemodynamic stability of a bolus administration of remimazolam during anesthesia induction in patients undergoing cardiac surgery. METHODS: Patients undergoing elective cardiac surgery were randomly assigned to any 1 of the following 3 groups: anesthesia induction with a continuous infusion of remimazolam 6 mg/kg/h (continuous group), a single-bolus injection of remimazolam 0.1 mg/kg (bolus 0.1 group), or a single-bolus injection of remimazolam 0.2 mg/kg (bolus 0.2 group). Time to loss of responsiveness, defined as modified Observer's Assessment of Alertness/Sedation Scale <3, and changes in hemodynamic status during anesthetic induction were measured. RESULTS: Times to loss of responsiveness were 137 ± 20, 71 ± 35, and 48 ± 9 seconds in the continuous, bolus 0.1, and bolus 0.2 groups, respectively. The greatest mean difference was observed between the continuous and bolus 0.2 groups (89.0, 95% confidence interval [CI], 79.1-98.9), followed by the continuous and bolus 0.1 groups (65.8, 95% CI, 46.9-84.7), and lastly between the bolus 0.2 and bolus 0.1 groups (23.2, 95% CI, 6.6-39.8). No significant differences were found in terms of arterial blood pressures and heart rates of the patients. CONCLUSIONS: A single-bolus injection of remimazolam provided efficient anesthetic induction in patients undergoing cardiac surgery. A 0.2 mg/kg bolus injection of remimazolam resulted in the shortest time to loss of responsiveness among the 3 groups, without significantly altering the hemodynamic parameters. Therefore, this dosing can be considered a favorable anesthetic induction method for patients undergoing cardiac surgery.

2.
J Cardiothorac Vasc Anesth ; 38(9): 1923-1931, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-38960803

RESUMO

OBJECTIVES: To determine whether balanced solutions can reduce the incidence of acute kidney injury after off-pump coronary artery bypass surgery compared with saline. DESIGN: Randomized controlled trial. SETTING: Single tertiary care center. PARTICIPANTS: Patients who underwent off-pump coronary artery bypass surgery between June 2014 and July 2020. INTERVENTIONS: Balanced solution-based chloride-restrictive intravenous fluid strategy. MEASUREMENTS AND MAIN RESULTS: The primary outcome was acute kidney injury within 7 postoperative days, as defined by the 2012 Kidney Disease: Improving Global Outcomes Clinical Practice Guideline. The incidence of acute kidney injury was 4.4% (8/180) in the balanced group and 7.3% (13/178) in the saline group. The difference was not statistically significant (risk difference, -2.86%; 95% confidence interval [CI], -7.72% to 2.01%; risk ratio, 0.61, 95% CI, 0.26 to 1.43; p = 0.35). Compared with the balanced group, the saline group had higher levels of intraoperative serum chloride and lower base excess, which resulted in a lower pH. CONCLUSIONS: In patients undergoing off-pump bypass surgery with a normal estimated glomerular filtration rate, the intraoperative balanced solution-based chloride-restrictive intravenous fluid administration strategy did not decrease the rate of postoperative acute kidney injury compared with the saline-based chloride-liberal intravenous fluid administration strategy.


Assuntos
Injúria Renal Aguda , Ponte de Artéria Coronária sem Circulação Extracorpórea , Complicações Pós-Operatórias , Solução Salina , Humanos , Injúria Renal Aguda/prevenção & controle , Injúria Renal Aguda/etiologia , Injúria Renal Aguda/epidemiologia , Ponte de Artéria Coronária sem Circulação Extracorpórea/métodos , Ponte de Artéria Coronária sem Circulação Extracorpórea/efeitos adversos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Solução Salina/administração & dosagem , Complicações Pós-Operatórias/prevenção & controle , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/etiologia , Hidratação/métodos
3.
Medicina (Kaunas) ; 60(7)2024 Jun 21.
Artigo em Inglês | MEDLINE | ID: mdl-39064447

RESUMO

Background and Objective: Lung transplantation is the only life-extending therapy for end-stage pulmonary disease patients, but its risks necessitate an understanding of outcome predictors, with the frailty index and nutritional status being key assessment tools. This study aims to evaluate the relationship between preoperative frailty and nutritional indexes and the postoperative mortality rate in patients receiving lung transplants, and to determine which measure is a more potent predictor of outcomes. Materials and Methods: This study reviewed 185 adults who received lung transplants at a single medical center between January 2013 and May 2023. We primarily focused on postoperative 7-year overall survival. Other outcomes measured were short-term mortalities, acute rejection, kidney complications, infections, and re-transplantation. We compared the predictive abilities of preoperative nutritional and frailty indicators for survival using receiver operating characteristic curve analysis and identified factors affecting survival through regression analyses. Results: There were no significant differences in preoperative nutritional indicators between survivors and non-survivors. However, preoperative frailty indicators did differ significantly between these groups. Multivariate analysis revealed that the American Society of Anesthesiologists Class V, clinical frailty scale, and Charlson Comorbidity Index (CCI) were key predictors of 7-year overall survival. Of these, the CCI had the strongest predictive ability with an area under the curve of 0.755, followed by the modified frailty index at 0.731. Conclusions: Our study indicates that for critically ill patients undergoing lung transplantation, frailty indexes derived from preoperative patient history and functional autonomy are more effective in forecasting postoperative outcomes, including survival, than indexes related to preoperative nutritional status.


Assuntos
Estado Terminal , Fragilidade , Transplante de Pulmão , Estado Nutricional , Humanos , Feminino , Masculino , Transplante de Pulmão/mortalidade , Pessoa de Meia-Idade , Fragilidade/complicações , Estado Terminal/mortalidade , Adulto , Complicações Pós-Operatórias , Estudos Retrospectivos , Idoso , Curva ROC , Avaliação Nutricional
4.
J Med Syst ; 44(9): 171, 2020 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-32803733

RESUMO

Efficient operating room (OR) scheduling can improve OR utilization and reduce costs. We hypothesize that the scheduling office (ORSO) leading the modification scheduling process could increase OR utilization rate. Using retrospective data from a single tertiary hospital in two consecutive calendar years, we compared OR utilization rate, the number of daily cases and cumulative operative time in the pre- and post-implementation of scheduling process alteration. We operated about 100,609 cases in the OR during the study period. Daytime utilization rate increased from 85.6% to 89.4% (P < 0.001); overall OR utilization rate from 115.1% to 117.6% (P = 0.019); daily case numbers from 229.9 ± 7.3 to 239.6 ± 7.6 (P = 0.0.14); and cumulative operation time of total and daytime cases from 611.7 case-hour/day to 624.5 case-hour/day (P = 0.013) and from 510.8 case-hour/day to 533.8 case-hour/day (P < 0.001), respectively. Evening/night time case-hour significantly decreased from 100.9 case-hour/day to 90.7 case-hour/day (P < 0.001). The optimization of the scheduling process and coordination by the office during regular workhours resulted in enhanced OR efficiency. The OR scheduling office can act as a control tower to make OR management more flexible, which can improve efficiency and carry financial benefits in tertiary hospitals.


Assuntos
Eficiência Organizacional , Salas Cirúrgicas , Agendamento de Consultas , Humanos , Duração da Cirurgia , Admissão e Escalonamento de Pessoal , Estudos Retrospectivos , Centros de Atenção Terciária
5.
J Korean Med Sci ; 34(15): e120, 2019 Apr 22.
Artigo em Inglês | MEDLINE | ID: mdl-31001937

RESUMO

Bronchial thermoplasty is a nonpharmacological treatment for severe asthma that delivers thermal energy to the bronchial walls and reduces hypertrophied smooth muscle mass. Previous studies have shown its efficacy and safety, resulting in approval from the Food and Drug Administration in 2010. In Korea, the first bronchial thermoplasty was carried out in 2014; 4 patients have undergone the procedure so far. This case series presents the medical history and treatment outcomes of these 4 patients. All patients presented with uncontrolled asthma despite optimal medical treatment. Bronchial thermoplasty was performed at the right lower lobe, left lower lobe, and both upper lobes in order at 3-week intervals. All procedures were performed under general anesthesia. Two patients had significant decreases in exacerbations and required a lower dose of inhaled corticosteroids after the procedure. One patient had slightly fewer exacerbations but failed to reduce the use of systemic corticosteroids. One patient had no change in symptoms. One limitation of bronchial thermoplasty is the difficulty of predicting clinical responders. However, since more therapeutic options are needed in the management of severe asthma, especially T2-low asthma, discussion with experts about the feasibility and necessity of bronchial thermoplasty will ensure the best possible care.


Assuntos
Asma/terapia , Termoplastia Brônquica , Corticosteroides/uso terapêutico , Agonistas de Receptores Adrenérgicos beta 2/uso terapêutico , Adulto , Asma/diagnóstico , Asma/tratamento farmacológico , Broncoscopia , Feminino , Fluoroquinolonas/uso terapêutico , Fluticasona/uso terapêutico , Volume Expiratório Forçado , Humanos , Masculino , Pessoa de Meia-Idade , República da Coreia , Xinafoato de Salmeterol/uso terapêutico , Índice de Gravidade de Doença , Tomografia Computadorizada por Raios X
6.
BMC Surg ; 19(1): 15, 2019 Feb 04.
Artigo em Inglês | MEDLINE | ID: mdl-30717728

RESUMO

BACKGROUND: To improve prognosis after esophageal surgery, intraoperative fluid optimization is important. Herein, we hypothesized that hydroxyethyl starch administration during esophagectomy reduce the total amount of fluid infused and it could have a positive effect on postoperative complication occurrence and mortality. METHODS: All consecutive adult patients who underwent elective esophageal surgery for cancer were studied. The primary outcome was the development of composite complications including death, cardio-cerebrovascular complications, respiratory complications, renal complications, gastrointestinal complications, sepsis, empyema or abscess, and multi-organ failure. The relationship between perioperative variables and composite complication was evaluated using multivariable logistic regression. RESULTS: Of 892 patients analyzed, composite complications developed in 271 (30.4%). The higher hydroxyethyl starch ratio in total fluid had a negative relationship with the total fluid infusion amount (r = - 0.256, P <  0.001). In multivariable analysis, intraoperatively administered total fluid per weight per hour (odds ratio, 1.248; 95% CI, 1.153-1.351; P <  0.001) and HES-to-crystalloid ratio (odds ratio, 2.125; 95% CI, 1.521-2.969; P <  0.001) were associated with increased risks of postoperative composite outcomes. CONCLUSIONS: Although hydroxyethyl starch administration reduces the total fluid infusion amount during esophageal surgery for cancer, intravenous hydroxyethyl starch infusion is associated with an increasing risk of postoperative composite complications.


Assuntos
Neoplasias Esofágicas/cirurgia , Esofagectomia , Hidratação/efeitos adversos , Hidratação/métodos , Derivados de Hidroxietil Amido/efeitos adversos , Substitutos do Plasma/efeitos adversos , Idoso , Soluções Cristaloides/administração & dosagem , Soluções Cristaloides/efeitos adversos , Esofagectomia/efeitos adversos , Esofagectomia/mortalidade , Feminino , Humanos , Derivados de Hidroxietil Amido/administração & dosagem , Período Intraoperatório , Masculino , Pessoa de Meia-Idade , Morbidade , Substitutos do Plasma/administração & dosagem , Prognóstico , Estudos Retrospectivos
7.
J Cardiothorac Vasc Anesth ; 32(3): 1236-1242, 2018 06.
Artigo em Inglês | MEDLINE | ID: mdl-29128489

RESUMO

OBJECTIVE: To evaluate the prognostic impacts of postoperative increases in serum amino transaminases on 1-year mortality in patients who underwent coronary artery bypass graft. DESIGN: A retrospective analysis. SETTING: A tertiary care university hospital. PARTICIPANTS: A total of 1,950 patients who underwent coronary artery bypass graft. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Aspartate amino transaminase and alanine amino transaminase ratios were calculated as the ratio between the peak aspartate amino transaminase and alanine amino transaminase within the first 5 post-operative days and their respective upper limit of normal values. A ratio of 2.0 was seen to be the minimum for which a difference in 1-year mortality could be detected in univariate analysis, when considering simultaneously both aspartate amino transaminase and alanine amino transaminase ratios. Multivariable analysis showed an association between an aspartate amino transaminase ratio > 2.0 and increased 1-year mortality (hazard ratio [HR] 2.68, 95% confidence interval [CI] 1.42-5.05, P = 0.002), and also between both an aspartate amino transaminase and alanine amino transaminase ratio > 2.0 and increased 1-year mortality (HR 3.90, 95% CI 1.87-8.14, P < 0.001). However, increases in alanine amino transaminase only above the upper limit of normal were not associated with increased 1-year mortality. CONCLUSIONS: Postoperative increases in aspartate amino transaminase only and increases in both aspartate amino transaminase and alanine amino transaminase greater than twice the upper limit of normal were associated with increased 1-year mortality in patients undergoing coronary artery bypass graft.


Assuntos
Alanina Transaminase/metabolismo , Aspartato Aminotransferases/metabolismo , Ponte de Artéria Coronária/mortalidade , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Estudos Retrospectivos
8.
J Korean Med Sci ; 33(43): e282, 2018 Oct 22.
Artigo em Inglês | MEDLINE | ID: mdl-30344465

RESUMO

Lung transplantation is the only treatment for end-stage lung disease, but the problem of donor shortage is unresolved issue. Herein, we report the first case of living-donor lobar lung transplantation (LDLLT) in Korea. A 19-year-old woman patient with idiopathic pulmonary artery hypertension received her father's right lower lobe and her mother's left lower lobe after pneumonectomy of both lungs in 2017. The patient has recovered well and is enjoying normal social activity. We think that LDLLT could be an alternative approach to deceased donor lung transplantation to overcome the shortage of lung donors.


Assuntos
Hipertensão Pulmonar/terapia , Transplante de Pulmão , Cardiomegalia/patologia , Feminino , Humanos , Doadores Vivos , Pneumonectomia , República da Coreia , Resultado do Tratamento , Adulto Jovem
9.
Anesthesiology ; 124(5): 1001-11, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-26891150

RESUMO

BACKGROUND: Hypoalbuminemia may increase the risk of acute kidney injury (AKI). The authors investigated whether the immediate preoperative administration of 20% albumin solution affects the incidence of AKI after off-pump coronary artery bypass surgery. METHODS: In this prospective, single-center, randomized, parallel-arm double-blind trial, 220 patients with preoperative serum albumin levels less than 4.0 g/dl were administered 100, 200, or 300 ml of 20% human albumin according to the preoperative serum albumin level (3.5 to 3.9, 3.0 to 3.4, or less than 3.0 g/dl, respectively) or with an equal volume of saline before surgery. The primary outcome measure was AKI incidence after surgery. Postoperative AKI was defined by maximal AKI Network criteria based on creatinine changes. RESULTS: Patient characteristics and perioperative data except urine output during surgery were similar between the two groups studied, the albumin group and the control group. Urine output (median [interquartile range]) during surgery was higher in the albumin group (550 ml [315 to 980]) than in the control group (370 ml [230 to 670]; P = 0.006). The incidence of postoperative AKI in the albumin group was lower than that in the control group (14 [13.7%] vs. 26 [25.7%]; P = 0.048). There were no significant between-group differences in severe AKI, including renal replacement therapy, 30-day mortality, and other clinical outcomes. There were no significant adverse events. CONCLUSION: Administration of 20% exogenous albumin immediately before surgery increases urine output during surgery and reduces the risk of AKI after off-pump coronary artery bypass surgery in patients with a preoperative serum albumin level of less than 4.0 g/dl.


Assuntos
Injúria Renal Aguda/epidemiologia , Injúria Renal Aguda/prevenção & controle , Albuminas/uso terapêutico , Ponte de Artéria Coronária sem Circulação Extracorpórea/efeitos adversos , Hipoalbuminemia/prevenção & controle , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/prevenção & controle , Albumina Sérica/análise , Injúria Renal Aguda/mortalidade , Idoso , Ponte de Artéria Coronária sem Circulação Extracorpórea/mortalidade , Método Duplo-Cego , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Monitorização Intraoperatória , Complicações Pós-Operatórias/mortalidade , Estudos Prospectivos , Terapia de Substituição Renal , Resultado do Tratamento , Urodinâmica
10.
Eur Heart J ; 35(3): 176-83, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24014392

RESUMO

AIMS: The aim of this study was to evaluate whether remote ischaemic preconditioning (RIPC) combined with remote ischaemic postconditioning (RIPostC) improves the clinical outcomes of patients undergoing cardiac surgery. METHODS AND RESULTS: From June 2009 to November 2010, 1280 patients who underwent elective cardiac surgery were randomized into the RIPC with RIPostC group or the control group in the morning of the surgery. In the RIPC with RIPostC group, four cycles of 5-min ischaemia and 5-min reperfusion were administered twice to the upper limb-before cardiopulmonary bypass (CPB) or coronary anastomoses for RIPC and after CPB or coronary anastomoses for RIPostC. The primary endpoint was the composite of major adverse outcomes, including death, myocardial infarction, arrhythmia, stroke, coma, renal failure or dysfunction, respiratory failure, cardiogenic shock, gastrointestinal complication, and multiorgan failure. Remote ischaemic preconditioning with RIPostC did not reduce the composite outcome compared with the control group (38.0 vs. 38.1%, respectively; P = 0.998) and there was no difference in each major adverse outcome. The intensive care unit and hospital stays were not different between the two groups. However, in the off-pump coronary artery bypass surgery subgroup, multivariate logistic regression analysis revealed that RIPC with RIPostC was related to increased composite outcome (odds ratio: 1.54; 95% confidence interval: 1.02-2.30; P = 0.038). CONCLUSION: Remote ischaemic preconditioning with RIPostC by transient upper limb ischaemia did not improve clinical outcome in patients who underwent cardiac surgery.


Assuntos
Cardiopatias/cirurgia , Complicações Intraoperatórias/prevenção & controle , Pós-Condicionamento Isquêmico/métodos , Precondicionamento Isquêmico Miocárdico/métodos , Procedimentos Cirúrgicos Torácicos/métodos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Cuidados Críticos/estatística & dados numéricos , Feminino , Mortalidade Hospitalar , Humanos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/prevenção & controle , Estudos Prospectivos , Resultado do Tratamento , Adulto Jovem
11.
J Cardiothorac Vasc Anesth ; 28(3): 564-71, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24702816

RESUMO

OBJECTIVE: To evaluate the usefulness of renal regional oxygen saturation (renal rSO2) in predicting the risk of acute kidney injury (AKI) after cardiac surgery. DESIGN: A prospective observational study. SETTING: Tertiary care university hospital. PARTICIPANTS: One hundred patients undergoing cardiac surgery. INTERVENTIONS: Renal rSO2 was monitored continuously by near-infrared spectroscopy (NIRS) throughout the anesthetic period. MEASUREMENTS AND MAIN RESULTS: Postoperative AKI was defined using the Risk, Injury, Failure, Loss, and End-stage (RIFLE) criteria. Of 95 patients who were included in the final analysis, 34 patients developed AKI after surgery. Recorded renal rSO2 data were used to calculate the total duration of the time when renal rSO2 was below the threshold values of 70%, 65%, 60%, 55%, and 50%. The total periods when the renal rSO2 level was below each of the threshold values were significantly longer in patients with AKI than in those without AKI (p = 0.001 or p<0.001). Receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive power of renal rSO2 for AKI. The ROC curve analysis showed that renal rSO2 could predict the risk of AKI with statistical significance and that a renal rSO2<55% had the best performance (area under the curve-ROC, 0.777; 95% CI, 0.669-0.885; p<0.001). Multivariate logistic regression analysis revealed that AKI significantly correlated with the duration of renal rSO2<55% (p = 0.002) and logistic EuroSCORE (p = 0.007). CONCLUSIONS: Intraoperative renal regional oxygen desaturation can be a good predictor of AKI in adult patients undergoing cardiac surgery.


Assuntos
Injúria Renal Aguda/epidemiologia , Injúria Renal Aguda/etiologia , Procedimentos Cirúrgicos Cardíacos/métodos , Hipóxia/complicações , Complicações Intraoperatórias/etiologia , Rim/metabolismo , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/etiologia , Idoso , Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Ponte de Artéria Coronária , Feminino , Taxa de Filtração Glomerular , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Estudos Prospectivos , Espectroscopia de Luz Próxima ao Infravermelho , Resultado do Tratamento
12.
J Cardiothorac Vasc Anesth ; 28(4): 936-42, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24680132

RESUMO

OBJECTIVE: The purpose of this study was to identify perioperative risk factors for postoperative acute kidney injury (AKI) in patients undergoing esophageal cancer surgery. DESIGN: A retrospective analysis of the prospectively collected medical data. SETTING: A tertiary care university hospital. PARTICIPANTS: All consecutive adult patients (n=595) who underwent elective esophageal surgery for cancer between January 2005 and April 2012. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: AKI was defined by the AKI Network criteria based on serum creatinine changes within the first 48 hours after esophageal cancer surgery. The relationship between perioperative variables and AKI was evaluated using multivariate logistic regression. Postoperative AKI developed in 210 (35.3%) patients. Risk factors for AKI were body mass index (odds ratio [OR] 1.07; 95% confidence interval [CI] 1.01-1.14), preoperative serum albumin level (OR 0.52; 95% CI 0.33-0.84), use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers (OR 1.35; 95% CI 1.05-1.75), colloid infusion during surgery (OR 1.11; 95% CI 1.06-1.18), and postoperative 2-day C-reactive protein (OR 1.05; 95% CI 1.01-1.09). Postoperative AKI was associated with prolonged length of hospital stay. CONCLUSIONS: Postoperative AKI is common in patients undergoing esophageal surgery for cancer. Closer evaluation and monitoring in patients with risk factors for AKI may be warranted.


Assuntos
Injúria Renal Aguda/epidemiologia , Neoplasias Esofágicas/cirurgia , Esofagectomia/efeitos adversos , Complicações Pós-Operatórias/epidemiologia , Medição de Risco , Injúria Renal Aguda/etiologia , Injúria Renal Aguda/fisiopatologia , Adulto , Feminino , Humanos , Incidência , Testes de Função Renal , Masculino , Pessoa de Meia-Idade , Razão de Chances , República da Coreia/epidemiologia , Estudos Retrospectivos , Fatores de Risco
13.
J Cardiothorac Vasc Anesth ; 28(6): 1440-7, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25245579

RESUMO

OBJECTIVE: Recent studies suggested that elevated serum uric acid levels may be associated with the risk of acute kidney injury (AKI) in several settings. However, the effect of uric acid on the risk of AKI after cardiovascular surgery remains uncertain. DESIGN: A retrospective analysis. SETTING: A tertiary care university hospital. PARTICIPANTS: All consecutive adult patients (n = 1,019) who underwent cardiovascular surgery between January 2011 and May 2012. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Preoperative and perioperative data were assessed in the study population. AKI was defined and staged as serum creatinine concentration-based Acute Kidney Injury Network criteria. Univariate and multivariate logistic regression analyses were conducted to evaluate the association between preoperative uric acid and postoperative AKI. Preoperative elevated uric acid (≥ 6.5 mg/dL) was associated independently with AKI after cardiovascular surgery (odds ratio 1.46; 95% confidence interval 1.04-2.06, p = 0.030). Results were the same in subgroup analyses. Preoperative elevated uric acid (≥ 6.5 mg/dL) also was associated with a higher incidence of prolonged ICU and hospital stay. CONCLUSIONS: Preoperative elevated serum uric acid is an independent risk factor for AKI in patients undergoing cardiovascular surgery. This finding suggests that preoperative measurements of serum uric acid concentration may help stratify risks for AKI in these patients.


Assuntos
Injúria Renal Aguda/sangue , Procedimentos Cirúrgicos Cardiovasculares , Complicações Pós-Operatórias/sangue , Período Pré-Operatório , Ácido Úrico/sangue , Idoso , Feminino , Humanos , Tempo de Internação/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Valor Preditivo dos Testes , Estudos Retrospectivos , Fatores de Risco
14.
Korean J Anesthesiol ; 2024 Jul 23.
Artigo em Inglês | MEDLINE | ID: mdl-39039823

RESUMO

Background: Minimalist transcatheter aortic valve replacement (TAVR) under monitored anesthesia care (MAC) emphasizes early recovery. Remimazolam is a novel benzodiazepine with a short recovery time. This study hypothesized that remimazolam is non-inferior to dexmedetomidine in terms of recovery after TAVR. Methods: In this retrospective observational study, remimazolam was compared to dexmedetomidine in patients who underwent TAVR under MAC at a tertiary academic hospital between July 2020 and July 2022. The primary outcome was timely recovery after TAVR, defined as discharge from the intensive care unit within the first day following the procedure. Propensity score matching was used to compare timely recovery between remimazolam and dexmedetomidine, applying a non-inferiority margin of -10%. Results: The study included 464 patients, of whom 218 received remimazolam and 246 received dexmedetomidine. After propensity score matching, 164 patients in each group were included in the analysis. Regarding timely recovery after TAVR, remimazolam was non-inferior to dexmedetomidine (152 of 164 [92.7%] in the remimazolam group versus 153 of 164 [93.3%] in the dexmedetomidine group, risk difference [95% CI]: -0.6% [-6.7% to 5.5%]). The use of remimazolam was associated with fewer postoperative vasopressors/inotropes (21 of 164 [12.8%] vs. 39 of 164 [23.8%]) and temporary pacemakers (TPMs) (76 of 164 [46.3%] vs. 108 of 164 [65.9%]) compared to dexmedetomidine. Conclusions: In patients undergoing TAVR under MAC, remimazolam was non-inferior to dexmedetomidine in terms of timely recovery. Remimazolam may be associated with better postoperative recovery profiles, including a lesser need for vasopressors/inotropes and TPMs.

15.
Anesthesiology ; 116(2): 362-71, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22222471

RESUMO

BACKGROUND: The ratio of early transmitral flow velocity to early diastolic velocity of the mitral annulus (E/e') correlates with left ventricular (LV) filling pressure. In particular, an E/e' ratio more than 15 is an excellent predictor of increased LV filling pressure. The authors evaluated the prognostic implications of preoperative estimated LV filling pressure, assessed by E/e' ratio, in patients undergoing off-pump coronary artery bypass graft surgery. METHODS: This observational study investigated 1,048 consecutive adults undergoing elective off-pump coronary artery bypass graft surgery. The primary outcome was occurrence of major adverse cardiac events (MACE), defined as a composite of death, myocardial infarction, malignant ventricular arrhythmia, cardiac dysfunction, or need for new revascularization. Logistic regression and survival analyses were performed. RESULTS: An E/e' ratio more than 15 was independently associated with 30-day MACE (odds ratio 2.4, 95% CI 1.4-3.9, P = 0.001) and 1-yr MACE (hazard ratio 2.1, 95% CI 1.4-3.1, P = 0.001), irrespective of underlying LV ejection fraction. MACE free 1-yr survival rate was significantly decreased in patients with E/e' >15, irrespective of underlying LV ejection fraction. CONCLUSIONS: Increased LV filling pressure, assessed by E/e' ratio, is an independent predictor of 30-day and 1-yr MACE in patients who undergo elective off-pump coronary artery bypass graft surgery. These findings indicate that measurements of E/e' may assist in preoperative risk stratification of these patients.


Assuntos
Ponte de Artéria Coronária sem Circulação Extracorpórea/efeitos adversos , Diástole/fisiologia , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/fisiopatologia , Cuidados Pré-Operatórios , Volume Sistólico/fisiologia , Sístole/fisiologia , Idoso , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/fisiopatologia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/etiologia , Cuidados Pré-Operatórios/métodos , Prognóstico , Função Ventricular Esquerda/fisiologia
16.
J Cardiothorac Vasc Anesth ; 26(6): 994-8, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22784862

RESUMO

OBJECTIVE: The unloading effect of anesthesia on the left ventricle results in a downgrade of mitral regurgitation (MR) severity, which increases as anesthesia deepens. This study examined how the depth of anesthesia could affect the loading condition of the left ventricle and the severity of MR. DESIGN: A prospective study. SETTING: Cardiac operating room at a single institution. PARTICIPANTS: Twenty patients with functional MR and 20 patients with organic MR. INTERVENTIONS: Different anesthetic depths determined by bispectral index (BIS) monitoring. MEASUREMENTS AND MAIN RESULTS: In patients with functional MR, maximal regurgitant jet area (JA), the vena contracta (VC) width, and the proximal isovelocity surface area (PISA) radius were significantly smaller at a low BIS than at a high BIS (JA, 2.4 cm(2), 1.9-4.7, v 5.0 cm(2), 3.4-6.7, p < 0.001; VC width, 2.7 ± 1.6 v 4.2 ± 1.4 mm, p < 0.001; PISA radius, 3.3 ± 2.3 v 5.6 ± 2.4 mm, p < 0.001). Similarly, in patients with organic MR, JA, VC width, and PISA radius were significantly smaller at a low BIS than at a high BIS (JA, 7.0 ± 2.4 v 9.7 ± 3.6 cm(2), p = 0.002; VC width, 5.7 mm, 4.1-6.6, v 7.1 mm, 5.4-8.4, p < 0.001; PISA radius, 9.0 ± 2.8 v 12.0 ± 3.3 mm, p < 0.001). CONCLUSIONS: It may be helpful to measure the severity of MR at a shallower anesthesia depth guided by BIS monitoring to avoid a downgrade of MR under general anesthesia.


Assuntos
Anestesia Geral/métodos , Ecocardiografia Transesofagiana/métodos , Insuficiência da Valva Mitral/diagnóstico por imagem , Insuficiência da Valva Mitral/patologia , Índice de Gravidade de Doença , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Resultado do Tratamento
17.
J Cardiothorac Vasc Anesth ; 25(1): 85-9, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20346703

RESUMO

OBJECTIVE: To investigate whether expired pump carbon dioxide (PepCO(2)) is an effective arterial carbon dioxide (PaCO(2)) monitor during cardiopulmonary bypass (CPB) in patients undergoing robotic cardiac surgery compared with traditional cardiac surgery. DESIGN: A prospective control study. SETTING: A university, single-institutional setting. PARTICIPANTS: Sixty patients undergoing cardiac surgery. INTERVENTIONS: PepCO(2) was measured using a standard multigas analyzer with the monitoring catheter connected to the exhaust port of the oxygenator. The authors measured PaCO(2) values of the arterial blood provided to the patient and PepCO(2) from the oxygenator exhaust outlet during the cooling, stable hypothermia, and rewarming phases of CPB. MEASUREMENTS AND MAIN RESULTS: There were significant differences between temperature-uncorrected PaCO(2) (PaCO(2)tu) and PepCO(2) measured during the cooling phase; between temperature-corrected PaCO(2) (PaCO(2)tc) and PepCO(2); and between PaCO(2)tu and PepCO(2) measured during the stable hypothermia phase between the 2 groups (p < 0.001 for all). However, there were no significant differences between PaCO(2)tc and PepCO(2) measured during the cooling phase or between PaCO(2)tc and PepCO(2) or PaCO(2)tu and PepCO(2) measured during the rewarming phase between the 2 groups (p = 0.453, p = 0.122, and p = 0.412, respectively). CONCLUSION: These results reveal that PepCO(2) is not suitable for continuous monitoring of PaCO(2) during CPB in patients undergoing robotic cardiac surgery.


Assuntos
Dióxido de Carbono/sangue , Dióxido de Carbono/metabolismo , Procedimentos Cirúrgicos Cardíacos/métodos , Robótica , Idoso , Temperatura Corporal , Capnografia , Ponte de Artéria Coronária , Feminino , Implante de Prótese de Valva Cardíaca , Hemodinâmica/fisiologia , Humanos , Hipotermia Induzida , Masculino , Pessoa de Meia-Idade , Valva Mitral/cirurgia , Oxigenadores , Reaquecimento
18.
J Cardiothorac Vasc Anesth ; 25(3): 462-8, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21093290

RESUMO

OBJECTIVE: The authors aimed to investigate whether immediate postoperative hypoalbuminemia could be associated with outcomes after off-pump coronary artery bypass graft (OPCAB) surgery. DESIGN: A retrospective analysis of the medical data. SETTING: Cardiac operating room and adult cardiovascular intensive care unit at a single institution. PARTICIPANTS: Six hundred ninety adult patients underwent elective OPCAB surgery over a 30-month period. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: To evaluate the clinical relevance of immediate postoperative hypoalbuminemia, the lowest serum albumin level measured over the first 12 hours postoperatively was recorded. A cutoff point was calculated by the area under the curve in the receiver operating characteristic plot for 30-day adverse events including death. Patients were classified according to the cutoff value, and outcomes were compared between groups using propensity score-matching analysis. The impact of immediate postoperative hypoalbuminemia on OPCAB outcome was investigated using multivariate analysis. The cutoff value for immediate postoperative albumin concentration for predicting 30-day adverse events was 2.3 g/dL. Immediate postoperative hypoalbuminemia (<2.3 g/dL) was associated independently with postoperative respiratory failure (odds ratio [OR] = 8.85, p = 0.04), wound infection (OR = 4.44, p = 0.04), the need for an intra-aortic balloon pump after the operation (OR = 13.7, p = 0.02), renal failure (OR = 7.98, p = 0.01), reoperation for bleeding (OR = 4.33, p = 0.05), and the need for inotropes in the intensive care unit (OR = 1.79, p = 0.02). CONCLUSIONS: Immediate postoperative hypoalbuminemia was associated with poorer outcomes in OPCAB patients. Monitoring of albumin levels after OPCAB could identify patients at risk for short-term adverse events.


Assuntos
Ponte de Artéria Coronária sem Circulação Extracorpórea/efeitos adversos , Hipoalbuminemia/etiologia , Hipoalbuminemia/mortalidade , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/mortalidade , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento
19.
J Korean Med Sci ; 25(7): 1083-5, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20592904

RESUMO

Airway management during carinal resection should provide adequate ventilation and oxygenation as well as a good surgical field, but without complications such as barotraumas or aspiration. One method of airway management is high frequency jet ventilation (HFJV) of one lung or both lungs. We describe a patient undergoing carinal resection, who was managed with HFJV of one lung, using a de-ballooned bronchial blocker of a Univent tube without cardiopulmonary compromise. HFJV of one lung using a bronchial blocker of a Univent tube is a simple and safe method which does not need additional catheters to perform HFJV and enables the position of the stiffer bronchial blocker more stable in airway when employed during carinal resection.


Assuntos
Ventilação em Jatos de Alta Frequência/instrumentação , Ventilação em Jatos de Alta Frequência/métodos , Neoplasias Pulmonares/cirurgia , Pulmão/cirurgia , Procedimentos Cirúrgicos Pulmonares/instrumentação , Procedimentos Cirúrgicos Pulmonares/métodos , Humanos , Masculino , Pessoa de Meia-Idade
20.
Sci Rep ; 10(1): 12968, 2020 07 31.
Artigo em Inglês | MEDLINE | ID: mdl-32737380

RESUMO

Transit-time flow measurement (TTFM) is frequently used to evaluate intraoperative quality control during coronary artery bypass grafting (CABG) and has the ability to assess graft failure intraoperatively. However, perioperative factors affecting TTFM during CABG remain poorly understood. Patients who underwent CABG at a single institution between July 2016 and May 2018 were prospectively evaluated. TTFM and blood viscosity were measured haemodynamically, while mean flow (mL/min), pulsatility index, and diastolic filling were recorded. Arterial blood gas was analysed immediately after left internal mammary artery to left descending artery anastomosis and before sternal closure. Factors associated with TTFM were assessed using multiple linear regression analysis. We evaluated 57 of the 62 patients who underwent CABG during the study period, including 49 who underwent off-pump and 8 who underwent on-pump surgeries. Blood viscosity was not significantly associated with TTFM (p > 0.05). However, TTFM was significantly associated with body mass index, systolic blood pressure, and cardiac index (p < 0.05 each). In conclusion, maintaining the SBP in the perioperative period and maintaining the CI with inotropic support or fluid resuscitation can be important in improving blood flow of graft vessels after surgery.


Assuntos
Ponte de Artéria Coronária , Circulação Coronária , Cuidados Intraoperatórios , Artéria Torácica Interna/fisiopatologia , Idoso , Velocidade do Fluxo Sanguíneo , Viscosidade Sanguínea , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Projetos Piloto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA